Harbin Gloria Pharmaceuticals (002437) — Cash Flow Quality Index
Harbin Gloria Pharmaceuticals (002437) has a Cash Flow Quality Index of 1.67x as of September 2025. Operating cash flow of CN¥182.89 Million exceeds net income of CN¥109.34 Million, indicating high earnings quality where cash backs reported profits. Explore 002437 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Harbin Gloria Pharmaceuticals Cash Flow Quality Index (2007–2025)
Historical Cash Flow Quality Index for Harbin Gloria Pharmaceuticals across 17 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Harbin Gloria Pharmaceuticals (002437) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Harbin Gloria Pharmaceuticals (2007–2025)
Year-by-year earnings quality comparison for Harbin Gloria Pharmaceuticals. For live market cap and the full company financial profile, see Harbin Gloria Pharmaceuticals market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.73x | CN¥273.36 Million | CN¥376.91 Million | ▼ -57.2% |
| 2024 | 1.69x | CN¥410.94 Million | CN¥242.54 Million | ▼ -20.5% |
| 2023 | 2.13x | CN¥274.18 Million | CN¥128.70 Million | ▼ -58.2% |
| 2021 | 5.09x | CN¥274.18 Million | CN¥53.84 Million | ▲ +16206.3% |
| 2020 | 0.03x | CN¥12.76 Million | CN¥408.68 Million | ▼ -99.7% |
| 2018 | 9.03x | CN¥1.16 Billion | CN¥128.77 Million | ▲ +322.9% |
| 2017 | 2.14x | CN¥651.80 Million | CN¥305.27 Million | ▲ +49.5% |
| 2016 | 1.43x | CN¥1.04 Billion | CN¥728.40 Million | ▲ +42.6% |
| 2015 | 1.00x | CN¥702.05 Million | CN¥701.03 Million | ▼ -32.3% |
| 2014 | 1.48x | CN¥674.04 Million | CN¥455.66 Million | ▼ -25.0% |
| 2013 | 1.97x | CN¥453.02 Million | CN¥229.60 Million | ▲ +56.7% |
| 2012 | 1.26x | CN¥205.89 Million | CN¥163.47 Million | ▲ +14.1% |
| 2011 | 1.10x | CN¥128.61 Million | CN¥116.51 Million | ▲ +51.7% |
| 2010 | 0.73x | CN¥112.59 Million | CN¥154.71 Million | ▼ -44.5% |
| 2009 | 1.31x | CN¥170.82 Million | CN¥130.24 Million | ▲ +140.4% |
| 2008 | 0.55x | CN¥57.81 Million | CN¥105.95 Million | ▼ -21.9% |
| 2007 | 0.70x | CN¥52.26 Million | CN¥74.76 Million | — |